Pending Spin-Off Its Advanced Molecular Services G
Post# of 895
On July 12, 2017, the Company announced plans to spin off its Advanced Molecular Services Group ("AMSG" as an independent publicly traded company by way of a tax-free distribution to Rennova stockholders. While this spin off has not been completed at the end of September 2017 as originally planned there is no change in the plan to do so
Advanced Molecular Services Group, Inc. develops systems, proprietary clinical data, patented molecular testing, and machine learning/artificial intelligence. The company focuses on mental and behavioral health, oncology, urology, and cardiovascular disease. It provides advanced machine learning in precision medicine to patients, physicians, and care teams in the United States. The company is based in West Palm Beach, Florida. Advanced Molecular Services Group, Inc. operates as a subsidiary of Rennova Health, Inc.
PB